MNCs Apply For IPR Of Chinese-Invented TCMs And Sell Them In China
This article was originally published in PharmAsia News
Executive Summary
In recent years, foreign drug companies have been obtaining Chinese-invented drug formulations through buying or partnering with Chinese medicine businesses